Nektar Therapeutics pain drug for knee arthritis fails study – Reuters

by admin on September 27, 2013

Nektar Therapeutics pain drug for knee arthritis fails study
Reuters
(Reuters) – Nektar Therapeutics said its experimental drug to treat chronic pain in patients with arthritis of the knee failed to meet its main goal in a mid-stage clinical trial. The drugmaker's shares fell nearly 30 percent in extended trading on
Nektar Announces Preliminary Topline Results from Phase 2 Efficacy Study for PR Newswire (press release)
Nektar Therapeutics Says Phase 2 Study of NKTR-181 Misses Primary EndpointWall Street Journal
Nektar Phase 2 Study Of NKTR-181 Fails To Meet Primary End-Point – Quick FactsNASDAQ

all 9 news articles »

View full post on chronic pain – Google News

Previous post:

Next post: